Simulations Plus, Inc., is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions and quantitative systems pharmacology/toxicology models for drug-induced liver injury and nonalcoholic fatty liver disease. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical, biotechnology, and chemical agents. Our software is licensed to and used in the conduct of research by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, artificial intelligence, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for molecular property prediction from structure and physiologically based pharmacokinetic modeling and simulation.

Company:

     Simulations Plus, Inc.
 

Headquarters Address:

 42505 10th Street West
Lancaster, CA 93534
 

Main Telephone:

 6617237723
 

Website:

https://www.simulations-plus.com/

 

Type of Organization:

 Software Development & Consulting
 

Industry:

 Pharmaceutical
 

Key Executives:

CEO: Shawn O'Connor

Chairman: Walter Woltosz

CFO: John Kneisel

 

Investor Relations

Contact:

 Renee Bouche

Phone:

 661-723-7723

Email:

renee@simulations-plus.com

 

Lancaster Division President

Contact:

 John DiBella

Phone:

 661-723-7723

Email:

john.dibella@simulations-plus.com

 

CFO

Contact:

 John Kneisel

Phone:

 661-723-7723

Email:

johnk@simulations-plus.com